Shanghai Shyndec Pharmaceutical Co.,Ltd.’s Net Profit Rose 1% in First Three Quarters of 2021

Shanghai Shyndec Pharmaceutical Co.,Ltd. (上海现代制药股份有限公司) (600420.SH) reported a net profit of 799.7 million yuan in the first three quarters of 2021, up 1% year-on-year.

Meanwhile, the company posted 10.7 billion yuan in revenue, up 14.4% year-on-year.

At the end of the reporting period, it had 19.5 billion yuan in total assets and 9.1 billion yuan in total liabilities, with a liability-to-asset ratio of 46.6%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.